Home/Filings/4/0001606498-24-000050
4//SEC Filing

Holbrook Kerr 4

Accession 0001606498-24-000050

CIK 0001606498other

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 4:10 PM ET

Size

8.4 KB

Accession

0001606498-24-000050

Insider Transaction Report

Form 4
Period: 2024-03-18
Holbrook Kerr
SVP, Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-18+2,53189,727 total
  • Tax Payment

    Common Stock

    2024-03-18$19.09/sh756$14,43288,971 total
  • Tax Payment

    Common Stock

    2024-03-18$19.09/sh2,840$54,21686,131 total
Footnotes (3)
  • [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each PRSU is the economic eqiuvalent of one share of Common Stock.
  • [F2]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,531 PRSUs which vested on March 18, 2024.
  • [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 9,516 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each TRSU is the economic equivalent of one share of Common Stock.

Issuer

AVANOS MEDICAL, INC.

CIK 0001606498

Entity typeother

Related Parties

1
  • filerCIK 0001861246

Filing Metadata

Form type
4
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:10 PM ET
Size
8.4 KB